CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Chrousos Phaedra Director | Grant or award | +41,600 | 164,950 | ||
| 2025-06-05 | Chrousos Phaedra Director | Grant or award | +59,225 | 123,350 | ||
| 2024-05-22 | Chrousos Phaedra Director | Grant or award | +21,887 | 64,125 | ||
| 2024-05-22 | Chrousos Phaedra Director | Grant or award · Stock Option (right to buy) | +40,202 | 40,202 | ||
| 2023-06-08 | Chrousos Phaedra Director | Grant or award | +17,307 | 42,238 | ||
| 2023-06-08 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +33,960 | 33,960 | ||
| 2022-06-16 | Chrousos Phaedra Director | Grant or award | +12,006 | 24,931 | ||
| 2022-06-16 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +24,707 | 24,707 | ||
| 2021-06-14 | Chrousos Phaedra Director | Sale | −2,075 | $19.34 | $40K | 12,925 |
| 2021-06-10 | Chrousos Phaedra Director | Grant or award | +5,000 | 15,000 | ||
| 2021-06-10 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-11 | Chrousos Phaedra Director | Grant or award | +5,000 | 10,000 | ||
| 2020-06-11 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-06-13 | Chrousos Phaedra Director | Grant or award | +5,000 | 5,000 | ||
| 2019-06-13 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-04-23 | Chrousos Phaedra Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 |
Page 1 of 1 · 16 trades